Changeflow GovPing Healthcare & Life Sciences FDA Variance Approval Letter to DePaul University
Routine Guidance Added Final

FDA Variance Approval Letter to DePaul University

Email

Summary

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to DePaul University's Idea Realization Laboratory. This document signifies approval for a specific variance related to medical device development or testing.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to DePaul University's Idea Realization Laboratory. This document, identified by docket number FDA-2026-V-1761-0004, indicates that the university has received approval for a specific variance, likely related to the development, testing, or regulation of medical devices under FDA oversight.

While this is an approval for a specific entity, other educational institutions or research laboratories involved in medical device innovation may find this document informative regarding the FDA's variance approval process. Compliance officers should note that specific details regarding the nature of the variance and its implications are not publicly available in the provided summary, and further review of the attached document would be necessary for a comprehensive understanding of any potential impact on broader compliance strategies.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Variance Approval Letter from FDA CDRH to DePaul University, Idea Realization Laboratory

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-V-1761-0004
Docket
FDA-2026-V-1761-0004

Who this affects

Applies to
Educational institutions
Industry sector
6111 Higher Education 3345 Medical Device Manufacturing
Activity scope
Medical Device Development
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Research and Development

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!